Correlation among soluble markers and severity of disease in non-diabetic subjects with pre-mature coronary artery disease

Molecular and Cellular Biochemistry

Volumn 330, Issue 1-2, 2009, Pages 201-209

  Mahajan, Nitin ^a   Malik, Namita ^a   Bahl, Ajay ^a   Sharma, Yashpaul ^a   Dhawan, Veena ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Gensini score; MMP 9; Pre mature CAD; SRAGE; TIMP 1

Indexed keywords

ACETYLSALICYLIC ACID; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ANGIOCARDIOGRAPHY; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FAMILY HISTORY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE OF ONSET; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SOLUBILITY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; YOUNG ADULT;

EID: 73349088102     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0134-1     Document Type: Article

References (40)

1. R Gupta P Joshi V Mohan KS Reddy S Yusuf 2008 Epidemiology and causation of coronary hear disease and stroke in India Heart 94 16 26 10.1136/hrt.2007. 132951 10.1136/hrt.2007.132951 1:STN:280:DC%2BD2sjks1Gntw%3D%3D 18083949
2. VP Gupta R Gupta 1996 Meta-analysis of coronary heart disease prevalence in Indian Indian Heart J 48 241 245 1:STN:280:DyaK28zjsVSlug%3D%3D 8755007 (Pubitemid 126496338)
3. U Kaul SC Manchanda ML Bhatia 1986 Myocardial infarction in young Indian patients, risk factors and angiographic profile Am Heart J 112 71 75 10.1016/0002-8703(86)90680-0 10.1016/0002-8703(86)90680-0 1:STN:280: DyaL283msFeitg%3D%3D 3728290 (Pubitemid 16066256)
4. DB Pahlajani MH Chawal 1989 Coronary artery disease pattern in ice young J Assoc Physicians India 37 312 315 1:STN:280:DyaK3c7jtVWrtQ%3D%3D 2613637
5. DA Morrow PM Ridker 1999 High sensitivity C-reactive protein (hs-CRP): a novel risk marker in cardiovascular disease Prev Cardiol 1 13 16
6. TC Wu HB Leu WT Lin CP Lin SJ Lin JW Chen 2005 Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease Eur J Clin Invest 35 537 545 10.1111/j.1365-2362.2005.01548.x 10.1111/j.1365-2362.2005.01548.x 1:CAS:528:DC%2BD2MXhtV2is7bJ 16128859 (Pubitemid 41243296)
7. HB Leu CP Lin WT Lin, et al. 2004 Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein Chest 126 1032 1039 10.1378/chest.126.4.1032 10.1378/chest.126.4.1032 1:CAS:528: DC%2BD2cXhtValurzJ 15486359 (Pubitemid 39391227)
8. PM Ridker M Cushman MJ Stampfer RP Tracy CH Hennekens 1998 Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation 97 425 428 1:STN:280:DyaK1c7ktVKktQ%3D%3D 9490235
9. PM Ridker M Cushman MJ Stampfer RP Tracy CH Hennekens 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 973 979 10.1056/NEJM199704033361401 10.1056/NEJM199704033361401 1:CAS:528:DyaK2sXisFOrtL0%3D 9077376 (Pubitemid 27152782)
10. P Ferroni S Basili F Martini, et al. 2003 Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation J Investig Med 51 295 300 10.2310/6650.2003.3563 10.2310/6650.2003.3563 1:CAS:528:DC%2BD3sXoslyhurw%3D 14577520
11. S Blankenberg HJ Rupprecht O Poirier, et al. 2003 Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease Circulation 107 1579 1585 10.1161/01.CIR.0000058700. 41738.12 10.1161/01.CIR.0000058700.41738.12 1:CAS:528:DC%2BD3sXit12msLo%3D 12668489 (Pubitemid 36397324)
12. AC Newby 2005 Dual role of matrix metalloproteinases (Matrixns) in intimal thickening and atherosclerotic plaque rupture Physiol Rev 85 1 30 10.1152/physrev.00048.2003 10.1152/physrev.00048.2003 1:CAS:528: DC%2BD2MXotFalsw%3D%3D 15618476 (Pubitemid 40171256)
13. E Lubos R Schnabel HJ Rupprecht, et al. 2006 Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study Eur Heart J 27 150 156 10.1093/eurheartj/ehi582 10.1093/eurheartj/ehi582 1:CAS:528: DC%2BD28XhsVegtbo%3D 16230310 (Pubitemid 43069030)
14. G Basta 2008 Receptor for advanced glycation end products and atherosclerosis: From basic mechanisms to clinical implications Atherosclerosis 196 9 21 10.1016/j.atherosclerosis.2007.07.025 10.1016/j.atherosclerosis.2007. 07.025 1:CAS:528:DC%2BD1cXpt12ntg%3D%3D 17826783
15. D Geroldi C Falcone E Emanuele, et al. 2005 Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension J Hypertens 23 1725 1729 10.1097/01.hjh.0000177535.45785.64 10.1097/01.hjh.0000177535.45785.64 1:CAS:528:DC%2BD2MXnt1yku7w%3D 16093918 (Pubitemid 41233433)
16. E Emanuele A D'Angelo C Tomaino, et al. 2005 Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia Arch Neurol 62 1734 1736 10.1001/archneur.62.11.1734 10.1001/archneur.62.11.1734 16286548 (Pubitemid 41626671)
17. R Ghidoni L Benussi M Glionna M Franzoni D Geroldi E Emanuele G Binetti 2008 Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment J Neural Transm 115 1047 1050 10.1007/s00702-008-0069-9 10.1007/s00702-008-0069-9 1:CAS:528: DC%2BD1cXotV2mtLo%3D 18506386
18. C Falcone E Emanuele A D'Angelo MP Buzzi C Belvito M Cuccia D Geroldi 2005 Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men Arterioscler Thromb Vasc Biol 25 1032 1037 10.1161/01.ATV.0000160342.20342.00 10.1161/01.ATV.0000160342.20342.00 1:CAS:528:DC%2BD2MXjsVCjt7s%3D 15731496 (Pubitemid 40627851)
19. TA Pearson GA Mensah RW Alexander, et al. 2003 Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 499 511 10.1161/01.CIR.0000052939.59093.45 10.1161/01.CIR.0000052939.59093.45 12551878 (Pubitemid 36158056)
20. EA Enas 2001 Lipoprotein(a) is an important genetic risk factor for premature coronary artery disease in Asian Indians Am J Cardiol 88 201 202 10.1016/S0002-9149(01)01659-9 10.1016/S0002-9149(01)01659-9 1:STN:280: DC%2BD3MvhtlKqtA%3D%3D 11463059 (Pubitemid 32607716)
21. M Sharma NK Ganguly 2005 Premature coronary artery disease in Indians and its associated risk factors Vasc Health Risk Manag 1 217 225 17319107
22. (1997) World medical association declaration of Helsiniki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovascular Research 35:2-3
23. GG Gensini 1983 A more meaningful scoring system for determining the severity of coronary heart disease Am J Cardiol 51 606 607 10.1016/S0002- 9149(83)80105-2 10.1016/S0002-9149(83)80105-2 1:STN:280:DyaL3s7itlyitw%3D%3D 6823874 (Pubitemid 13187192)
24. WT Friedwald RI Levy DS Fredrickson 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 18 499 502
25. EA Enas S Yusuf JL Mehta 1992 Prevalence of coronary artery disease in Asian Indians Am J Cardiol 70 945 949 10.1016/0002-9149(92)90744-J 10.1016/0002-9149(92)90744-J 1:STN:280:DyaK38vhtFajtg%3D%3D 1529952
26. Indrayan I (2004) Burden of cardiovascular diseases in India. In: Burden of diseases in India. National Commission on Macroeconomics and Health, Government of India, New Delhi
27. BW Walsh LH Kuller RA Wild 1998 Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women JAMA 279 1445 1451 10.1001/jama.279.18.1445 10.1001/jama.279.18.1445 1:CAS:528:DyaK1cXjsVOgtLY%3D 9600478 (Pubitemid 28228201)
28. M Haidari E Javadi B Sadeghi M Hajilooi J Ghanbili 2001 Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease Clin Biochem 33 309 315 10.1016/S0009-9120(01) 00227-2 10.1016/S0009-9120(01)00227-2 (Pubitemid 32607574)
29. MC Tataru J Heinrich R Junker, et al. 2000 C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris Eur Heart J 21 1000 1008 10.1053/euhj.1999.1981 10.1053/euhj.1999.1981 1:CAS:528:DC%2BD3cXkt1eqsLw%3D 10901512 (Pubitemid 30312089)
30. N Rifai R Joubran H Yu M Asmi M Jouma 1999 Inflammatory markers in men with angiographically documented coronary heart disease Clin Chem 45 1967 1973 1:CAS:528:DyaK1MXnt1Gksrw%3D 10545067
31. I Abdelmouttaleb N Danchin C Ilardo, et al. 1999 C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes Am Heart J 137 346 351 10.1053/hj.1999.v137.92052 10.1053/hj.1999.v137.92052 1:CAS:528: DyaK1MXht1yitrc%3D 9924170 (Pubitemid 29070148)
32. MA Mendall DP Strachan BK Butland, et al. 2000 C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men Eur Heart J 21 1584 1590 10.1053/euhj.1999.1982 10.1053/euhj.1999.1982 1:CAS:528:DC%2BD3cXntlShsbo%3D 10988010 (Pubitemid 30736155)
33. RP Tracy BM Psaty E Macy, et al. 1997 Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects Arterioscler Thromb Vasc Biol 17 2167 2176 1:STN:280:DyaK1c%2Fht1Oguw%3D%3D 9351386
34. JL Anderson JF Carlquist JB Muhlestein BD Horne SP Elmer 1998 Evaluation of C-reactive protein, an inflammatory marker, and infection serology as risk factors for coronary artery disease and myocardial infarction J Am Coll Cardiol 32 35 41 10.1016/S0735-1097(98)00203-4 10.1016/S0735-1097(98)00203-4 1:CAS:528:DyaK1cXkslOlsLw%3D 9669246 (Pubitemid 28351039)
35. G Liuzzo LM Biasucci JR Gallamore, et al. 1994 The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina N Engl J Med 331 417 424 10.1056/NEJM199408183310701 10.1056/NEJM199408183310701 1:STN:280:DyaK2czgvFKruw%3D%3D 7880233 (Pubitemid 24247397)
36. Y Noji K Kajinami M Kawashiri, et al. 2001 Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis Clin Chem Lab Med 39 380 384 10.1515/CCLM.2001.060 10.1515/CCLM.2001.060 1:CAS:528:DC%2BD3MXlt1Kmsbs%3D 11434385 (Pubitemid 32529917)
37. A Kalela M Ponnio TA Koivu M Hoyhtya H Huhtala 2000 Association of serum sialic acid and MMP-9 with lipids and inflammatory markers Eur J Clin Invest 30 99 104 10.1046/j.1365-2362.2000.00607.x 10.1046/j.1365-2362.2000.00607.x 1:STN:280:DC%2BD3c7hslOjtw%3D%3D 10651833 (Pubitemid 30079566)
38. MH Tayebjee GY Lip RJ MacFadyen GYH Lip 2005 Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance Curr Med Chem 12 917 925 10.2174/0929867053507270 10.2174/0929867053507270 1:CAS:528:DC%2BD2MXjtVCjsb8%3D 15853705 (Pubitemid 40443847)
39. A Zaltsman S George A Newby 1999 Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity Arterioscler Thromb Vasc Biol 19 1700 1707 1:CAS:528:DyaK1MXkvV2lu7k%3D 10397688
40. H Koyama T Shoji H Yokoyama, et al. 2005 Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis Arterioscler Thromb Vasc Biol 25 2587 2593 10.1161/01.ATV. 0000190660.32863.cd 10.1161/01.ATV.0000190660.32863.cd 1:CAS:528: DC%2BD2MXht1Crt7rM 16224056 (Pubitemid 43732283)